Search Results (32)
Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation. | Academic Article |
Why?
|
EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. | Academic Article |
Why?
|
Molecular assessment of circulating exosomes toward liquid biopsy diagnosis of Ewing sarcoma family of tumors. | Academic Article |
Why?
|
Entinostat: A Promising Treatment Option for Refractory and Recurrent Ewing Sarcoma Patients | Grant |
Why?
|
Ewing’s Sarcoma Family of Tumors: Targeting Molecular Pathways and the Race for a Cure | Academic Article |
Why?
|
Ewing sarcoma family of tumors-derived small extracellular vesicle proteomics identify potential clinical biomarkers. | Academic Article |
Why?
|
Exosomal microRNAs to enhance chemosensitivity and advance precision medicine in pediatric Ewing Sarcoma | Grant |
Why?
|
Exosome miRNAs as biomarkers and targets for chemoresistance in Ewing Sarcoma | Grant |
Why?
|
Exosomes as biomarkers of disease and therapy-resistance in Ewing Sarcoma | Grant |
Why?
|
Exosomes as Biomarkers to Monitor Disease Progression and Response to Therapy in Ewing Sarcoma | Grant |
Why?
|
Sarcoma, Ewing | Concept |
Why?
|
Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. | Academic Article |
Why?
|
Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines. | Academic Article |
Why?
|
The Clinical Utility of Extracellular Vesicle miRNAs as Biomarkers of Chemosensitivity in Relapsed and Refractory Pediatric Ewing Sarcoma | Grant |
Why?
|
Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis. | Academic Article |
Why?
|